DE19375106I2 - Verfahren zur Herstellung einer parenteralen Dosiseinheit von lyophilisiertem N-Piperacillin - Google Patents

Verfahren zur Herstellung einer parenteralen Dosiseinheit von lyophilisiertem N-Piperacillin

Info

Publication number
DE19375106I2
DE19375106I2 DE1993175106 DE19375106C DE19375106I2 DE 19375106 I2 DE19375106 I2 DE 19375106I2 DE 1993175106 DE1993175106 DE 1993175106 DE 19375106 C DE19375106 C DE 19375106C DE 19375106 I2 DE19375106 I2 DE 19375106I2
Authority
DE
Germany
Prior art keywords
piperacillin
lyophilized
preparing
dosage unit
parenteral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1993175106
Other languages
German (de)
English (en)
Inventor
Bruce Haeger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Wyeth LLC
Original Assignee
Wyeth Holdings LLC
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19375106(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Holdings LLC, Wyeth LLC filed Critical Wyeth Holdings LLC
Application granted granted Critical
Publication of DE19375106I2 publication Critical patent/DE19375106I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1993175106 1981-03-26 1982-03-09 Verfahren zur Herstellung einer parenteralen Dosiseinheit von lyophilisiertem N-Piperacillin Active DE19375106I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26

Publications (1)

Publication Number Publication Date
DE19375106I2 true DE19375106I2 (de) 2006-02-16

Family

ID=22935482

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1993175106 Active DE19375106I2 (de) 1981-03-26 1982-03-09 Verfahren zur Herstellung einer parenteralen Dosiseinheit von lyophilisiertem N-Piperacillin
DE19823208505 Granted DE3208505A1 (de) 1981-03-26 1982-03-09 Mittel mit einem gehalt an einem lyophilisierten penicillinderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19823208505 Granted DE3208505A1 (de) 1981-03-26 1982-03-09 Mittel mit einem gehalt an einem lyophilisierten penicillinderivat

Country Status (23)

Country Link
JP (1) JPS57159708A (enrdf_load_stackoverflow)
AT (1) AT395533B (enrdf_load_stackoverflow)
AU (1) AU549784B2 (enrdf_load_stackoverflow)
BE (1) BE892541A (enrdf_load_stackoverflow)
CA (1) CA1209477A (enrdf_load_stackoverflow)
CH (1) CH652306A5 (enrdf_load_stackoverflow)
DE (2) DE19375106I2 (enrdf_load_stackoverflow)
DK (1) DK157976C (enrdf_load_stackoverflow)
ES (1) ES509234A0 (enrdf_load_stackoverflow)
FR (1) FR2502624B1 (enrdf_load_stackoverflow)
GB (1) GB2095551B (enrdf_load_stackoverflow)
GR (1) GR78386B (enrdf_load_stackoverflow)
HK (1) HK39189A (enrdf_load_stackoverflow)
HU (1) HU186489B (enrdf_load_stackoverflow)
IE (1) IE52936B1 (enrdf_load_stackoverflow)
IL (1) IL64924A (enrdf_load_stackoverflow)
IT (1) IT1147916B (enrdf_load_stackoverflow)
LU (1) LU84031A1 (enrdf_load_stackoverflow)
NL (1) NL192664C (enrdf_load_stackoverflow)
NZ (1) NZ199632A (enrdf_load_stackoverflow)
PL (1) PL130564B1 (enrdf_load_stackoverflow)
SE (1) SE453153B (enrdf_load_stackoverflow)
ZA (1) ZA82605B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) * 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
DK1675573T4 (da) 2003-10-23 2012-08-06 Otsuka Pharma Co Ltd Steril, injicerbr aripiprazol-formulering med kontrolleret frigivelse samt fremgangsmåde
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
KR101546106B1 (ko) 2007-07-31 2015-08-20 오쓰까 세이야꾸 가부시키가이샤 아리피프라졸 현탁액 및 냉동건조 제형의 제조 방법
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
LU84031A1 (de) 1982-07-08
PL235509A1 (enrdf_load_stackoverflow) 1982-12-20
ZA82605B (en) 1982-12-29
IT1147916B (it) 1986-11-26
FR2502624B1 (fr) 1985-10-25
SE8200591L (sv) 1982-09-27
DK157976C (da) 1990-08-27
NL192664C (nl) 1997-12-02
AU549784B2 (en) 1986-02-13
ATA92982A (de) 1992-06-15
NZ199632A (en) 1985-07-12
DK157976B (da) 1990-03-12
IL64924A0 (en) 1982-04-30
NL8201251A (nl) 1982-10-18
SE453153B (sv) 1988-01-18
ES8302455A1 (es) 1982-12-16
IT8248034A0 (it) 1982-03-19
JPS57159708A (en) 1982-10-01
GB2095551A (en) 1982-10-06
BE892541A (fr) 1982-09-20
IE52936B1 (en) 1988-04-13
DE3208505C2 (enrdf_load_stackoverflow) 1991-11-28
IL64924A (en) 1985-07-31
PL130564B1 (en) 1984-08-31
GB2095551B (en) 1984-10-03
GR78386B (enrdf_load_stackoverflow) 1984-09-26
DK48382A (da) 1982-09-27
DE3208505A1 (de) 1982-10-21
HU186489B (en) 1985-08-28
FR2502624A1 (fr) 1982-10-01
NL192664B (nl) 1997-08-01
CH652306A5 (de) 1985-11-15
IE820703L (en) 1982-09-26
AT395533B (de) 1993-01-25
HK39189A (en) 1989-05-19
JPH0219804B2 (enrdf_load_stackoverflow) 1990-05-07
ES509234A0 (es) 1982-12-16
CA1209477A (en) 1986-08-12
AU7986582A (en) 1982-09-30

Similar Documents

Publication Publication Date Title
PT80641A (de) Verfahren zur herstellung von dialkoxypyridinen
AT380476B (de) Verfahren zur herstellung von chinazolinderivaten
DE3230888A1 (de) Verfahren zur herstellung von verbundstoffen
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
DE69214889D1 (de) Verfahren zur Herstellung von Bisphenol A
AT387142B (de) Verfahren zur herstellung einer nitrofurantoin-dosierungsform
DE69128009D1 (de) Verfahren zur Herstellung von Tetrabrombisphenol A
DE69008373D1 (de) Verfahren zur Herstellung von Tetrabrombisphenol A.
DE3650643D1 (de) Verfahren zur Herstellung von 3-Polyfluoroalkylisoxazolylaminen
AT371744B (de) Verfahren zur herstellung von foerderschnecken
DE68925711D1 (de) Verfahren zur Herstellung von Alkadienolen
DE69217398D1 (de) Verfahren zur Herstellung von 9-deoxo-9(z)-hydroxyiminoerythromycin A
DE69214745D1 (de) Verfahren zur Herstellung von Bisphenol A
DE19375106I2 (de) Verfahren zur Herstellung einer parenteralen Dosiseinheit von lyophilisiertem N-Piperacillin
DE69032378D1 (de) Ein Verfahren zur Herstellung von Dibenzoxazolylthiophenen
DE3855937D1 (de) Verfahren zur Herstellung von 3-Chlor-4-fluornitrobenzol
DE3689160D1 (de) Verfahren zur Herstellung einer Polymerzusammensetzung.
ATA206287A (de) Verfahren zur herstellung einer backware
PT75940B (de) Verfahren zur herstellung von neuen 5-diazacycloalkylimidazo
DE58909673D1 (de) Verfahren zur Herstellung von Alkenylphosphinsäurealkylestern
PT80006B (de) Verfahren zur herstellung von 3-methyl-7-fluor-5-nitrobenzothiophen
DD160829A3 (de) Verfahren zur gewinnung von polybutylenterephthalat
DD222188A3 (de) Verfahren zur herstellung von substituierten 2-aminothiophenen
ATA354585A (de) Verfahren zur herstellung von krebszellen bekaempfenden lymphocyten
ATE84823T1 (de) Verfahren zur herstellung einer mischung von sacchariden.